According to the National Institutes of Health (NIH), cannabidiol (CBD) is defined as follows: Cannabidiol (CBD) is the major non-psychotropic cannabinoid compound derived from the plant Cannabis sativa, commonly known as marijuana. CBD was first isolated in 1940 and its structure and stereochemistry determined in 1963. Interest in utilizing the benefits of CBD therapeutically have increased due to the discovery of its antioxidative, anti-inflammatory, and neuroprotective effects, actions that occur for the most part independently of the canonical cannabinoid CB1 and CB2 receptors. CBD may prove to have therapeutic utility in a number of conditions involving both inflammation and oxidative stress.
Currently, there are many studies that show that CBD, as well as the other cannabinoids in hemp, interact with the endocannabinoid system of the human body. This complex system contributes to a wide range of biological processes including sleeping, appetite, relaxation, and inflammation responses. When CB1 and CB2 cannabinoid receptors in the body cells link with CBD, they interact with the user’s endocannabinoid system thereby regulating homeostasis or the natural balanced state of the body.